Janux Therapeutics, Inc. (JANX) is capturing the spotlight within the biotechnology sector, not only for its innovative approach to cancer treatment but also for its remarkable potential upside of 187.34%,..
Organon & Co. (NYSE: OGN) is a prominent player in the healthcare sector, specifically within the drug manufacturers industry. With a market capitalization of $1.84 billion, the company is a..
Select Medical Holdings Corporation (NYSE: SEM) is making waves in the healthcare sector with its diverse portfolio of medical care facilities. With a market capitalization of $1.76 billion, Select Medical..
Surgery Partners, Inc. (NASDAQ: SGRY), a significant player in the medical care facilities industry, stands as a compelling opportunity for investors eyeing the healthcare sector. With a market capitalization of..
Kymera Therapeutics, Inc. (NASDAQ: KYMR) is making waves in the biotechnology sector with its innovative approach to drug development, focusing on small molecule therapeutics that leverage the body’s natural protein..
Phreesia, Inc. (NYSE: PHR), a key player in the healthcare sector, offers a compelling investment narrative for investors seeking exposure to the rapidly evolving Health Information Services industry. With its..
MoonLake Immunotherapeutics (NASDAQ: MLTX), a Swiss-based clinical-stage biotechnology company, is capturing the attention of investors with its promising research in inflammatory skin and joint diseases. Despite the challenges inherent in..
PACS Group, Inc. (PACS), a prominent player in the healthcare sector, is capturing investor attention with its considerable potential upside of 175.13%. As a company specializing in skilled nursing and..
Enovis Corporation (ENOV), a key player in the healthcare sector’s medical device industry, presents a compelling case for investors seeking growth opportunities within this dynamic field. With a market capitalization..
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a clinical-stage biotechnology company based in Salt Lake City, Utah, is making waves in the healthcare sector with its innovative approach to drug discovery. By..
Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) stands out in the biotechnology sector, attracting significant attention from investors due to its innovative approach to treating rare neurological diseases. With a current..
Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is capturing the attention of investors with its promising 24.21% upside potential, as indicated by the average analyst target price. As a biopharmaceutical company focused..
Certara, Inc. (NASDAQ: CERT) stands as a prominent player in the health information services sector, specializing in technology-enabled solutions for biosimulation in drug development and regulatory submissions. With a market..
Alignment Healthcare, Inc. (NASDAQ: ALHC), a dynamic player in the healthcare sector, has been catching the eye of investors with its impressive 49% revenue growth. Specializing in Medicare Advantage plans,..
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is a noteworthy name in the biotechnology sector, commanding a market capitalization of $3.7 billion. Headquartered in Jupiter, Florida, Ligand is known for developing and..
Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a biopharmaceutical company specializing in peptide therapeutics, has been capturing investor interest with its robust pipeline and notable market presence. Operating within the healthcare sector..
Privia Health Group, Inc. (NASDAQ: PRVA) is making waves in the healthcare sector as a prominent player in the health information services industry. With a market capitalization of $3.16 billion,..
NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a burgeoning force in the biotechnology sector, has been capturing investor interest with its innovative approach to tackling metabolic diseases. Based in Naarden, Netherlands,..
Amicus Therapeutics, Inc. (NASDAQ: FOLD) is making waves in the biotechnology sector with its innovative approach to treating rare diseases. Headquartered in Princeton, New Jersey, this healthcare-focused company holds a..
Centessa Pharmaceuticals plc (NASDAQ: CNTA), a clinical-stage biotechnology company headquartered in Altrincham, UK, is capturing the attention of investors with its robust pipeline targeting unmet medical needs. With a market..
